Microwave-assisted multi-component green synthesis of bioactive pyrazol-5-ol and its derivatives using graphene oxide as a recyclable catalyst: a route to EGFR inhibitors.
1/5 보강
Traditional methods for synthesizing heterocyclic compounds often involve multistep procedures and harsh conditions, leading to environmental concerns and inefficient use of resources.
APA
Chaudhari D, Jana S, et al. (2025). Microwave-assisted multi-component green synthesis of bioactive pyrazol-5-ol and its derivatives using graphene oxide as a recyclable catalyst: a route to EGFR inhibitors.. RSC advances, 15(51), 43542-43563. https://doi.org/10.1039/d5ra06014a
MLA
Chaudhari D, et al.. "Microwave-assisted multi-component green synthesis of bioactive pyrazol-5-ol and its derivatives using graphene oxide as a recyclable catalyst: a route to EGFR inhibitors.." RSC advances, vol. 15, no. 51, 2025, pp. 43542-43563.
PMID
41220629
Abstract
Traditional methods for synthesizing heterocyclic compounds often involve multistep procedures and harsh conditions, leading to environmental concerns and inefficient use of resources. Herein, a sustainable and rapid microwave-assisted multi-component reaction (MCR) strategy was developed for the synthesis of 3-methyl-4-(2-nitro-1-phenylethyl)-1-pyrazol-5-ol (4) using graphene oxide (GO) as a heterogeneous catalyst in various polar solvents. Under optimized conditions (180 W, 4 min, 0.05 wt% GO in water), the reaction afforded up to 95% yield. GO, synthesized a modified Hummers' method, exhibited excellent catalytic efficiency and reusability over five consecutive cycles with minimal loss of activity. Structural analyses (XRD, XPS, Raman, FT-IR, TGA, and TEM) revealed that GO retained its nanoscale flake-like morphology (∼5-9 nm crystallite size), few-layered sheet structure, and partially ordered graphitic domains even after repeated microwave exposure, confirming its thermal and structural stability. The optimized protocol efficiently accommodated various substituted reactants, yielding pyrazol-5-ol derivatives (4, 6 and 8 series) in the range of 80-96%. Computational docking of all synthesized compounds against EGFR tyrosine kinase (PDB ID: 1M17) showed favourable π-π stacking and hydrogen bonding interactions, while compound 6a exhibited the strongest binding affinity and potent cytotoxicity toward human lung cancer (A549) cells (IC = 15.29 μM). This green, fast, and reusable GO-catalysed MCR approach offers a promising route for the sustainable development of EGFR-targeted anticancer agents.